News

Harbour BioMed declared that it ventures into licensing agreement with BeiGene for producing human therapeutic monoclonal antibodies to a commercial-stage biopharmaceutical company that…
Read More...

Biotechnology company heralding a new class of therapeutics based on its bicyclic peptide product platform has been provided grant from Innovate UK to develop next generation of novel…
Read More...

Xcell Biosciences initiates to accelerate its goal by considering new market opportunities in immunotherapy drug research and development. It has exhibited excellence in new…
Read More...

Clinical stage biopharmaceutical company into discovering and developing Pentarins which is a new class of potent and selective cancer medicines announced the appointment of Brian…
Read More...

AvantGen collaborates with Tanabe Research Laboratories for successful completion of first cancer therapeutic antibody discovery program. AvantGen is accountable for producing novel…
Read More...

U.S.-based multi platform gene therapy company pronounces completion of merger with Inotek pharmaceuticals that looks to combat rare diseases. The inclusive company to emphasize on…
Read More...

In a bid to replace its expired base shelf prospectus and corresponding shelf registration statement on form F-10, Aurinia Pharmaceuticals files new tentative base shelf prospectus …
Read More...

Committed to developing and commercialising products to cure rare diseases proclaims granting US patent entitled Novel Peptides and Analogs for Use in the Treatment of Oral Mucositis.…
Read More...

PharmaMar enters into a distribution license agreement with Megapharm for the commercialisation of anticancer drug Aplidin (plitidepsin) in Israel derived from marine. As per the…
Read More...

Indivior declares collaboration with Addex Pharma to accelerate GABAB positive allosteric modulators (PAMs). It has previously recorded preclinical efficacy in animal models for alcohol…
Read More...

Taiwan and US based biopharmaceutical company, Foresee pharmaceutical Co., Ltd. ventures into an exclusive license and distribution agreement with an Israel based biopharmaceutical…
Read More...

U.S FDA has accepted the IND application for ASN007, a selective ERK ½ inhibitor as declared by Asana BioSciences which specialises in oncology nd a clinical stage biopharmaceutical…
Read More...

Genecentric Therapeutics Inc. Proclaimed a research collaboration to assess the potential of Genecentric’s Cancer Subtype Platform in order to detect responders to G1 Therapeutic’s oral…
Read More...

Novaquest Capital Management announced acquisition of Viamet Pharmaceuticals including the company’s product candidate, VT-1161 that successfully complete phase 2b clinical trials for…
Read More...

ArunA Biomedical officially launches of a new class exosome biologics to cure central nervous system and neurogenerative disorders. The company published conclusions of a study…
Read More...

Clinical biopharmaceutical company, Liquidia dedicated to accelerate the performance of precision medicine by accurately engineering drug particles announces to commence the evolution…
Read More...

Pharmaceutical Product Development, LLC asserts Colin Hill, an acclaimed name in the health care technology and a connoisseur in precision medicine to its board of directors. He is…
Read More...

Leading venture backed microbiome company growing novel molecular therapeutics based on the human microbiome, asserted that it intends to enter into an agreement with Paragon…
Read More...

Advanced precision medicine CIRCULOGENE through its molecular genetics testing enters into an international licensing agreement with turkey based CIRCULOGENE Saglik. As per the terms…
Read More...

CanniMed Therapeutics Inc’s wholly owned subsidiary Sub Terra LLC moves to produce and process medical cannabis through its State of Michigan licenses application. The company has…
Read More...